Literature DB >> 29296735

Effects of hemin and hemodialysis in a patient with acute intermittent porphyria and renal failure.

Shirin Attarian1, Chunli Yu2, Karl E Anderson3,4, Ellen W Friedman1.   

Abstract

Hemin and hemodialysis had an additive effect in decreasing ALA and PBG in our patient with acute intermittent porphyria and renal failure.The time course of ALA and PBG reaccumulation after hemodialysis is not known.

Entities:  

Year:  2017        PMID： 29296735      PMCID： PMC5737596          DOI： 10.1182/bloodadvances.2017005660

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  12 in total

1.  High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.

Authors:  Nicolas Pallet; Iadh Mami; Caroline Schmitt; Zoubida Karim; Arnaud François; Marion Rabant; Dominique Nochy; Laurent Gouya; Jean-Charles Deybach; Yichum Xu-Dubois; Eric Thervet; Hervé Puy; Alexandre Karras
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

2.  [Hemodialysis therapy of acute intermittent porphyria].

Authors:  K Schirmer; H Röder
Journal:  Z Gesamte Inn Med       Date:  1973-10-01

3.  Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease.

Authors:  Brenden Chen; Constanza Solis-Villa; Jörg Hakenberg; Wanqiong Qiao; Ramakrishnan R Srinivasan; Makiko Yasuda; Manisha Balwani; Dana Doheny; Inga Peter; Rong Chen; Robert J Desnick
Journal:  Hum Mutat       Date:  2016-09-05       Impact factor: 4.878

4.  Hypertension and renal impairment as complications of acute porphyria.

Authors:  S E Church; K E McColl; M R Moore; G R Youngs
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

5.  Charcoal haemoperfusion and haemodialysis in acute intermittent porphyria.

Authors:  A C Laiwah; B Junor; G J MacPhee; G G Thompson; K E McColl
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

6.  Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes.

Authors:  E Sardh; D E H Andersson; A Henrichson; P Harper
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2009-02-16       Impact factor: 1.770

7.  Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.

Authors:  Herbert L Bonkovsky; Vinaya C Maddukuri; Cemal Yazici; Karl E Anderson; D Montgomery Bissell; Joseph R Bloomer; John D Phillips; Hetanshi Naik; Inga Peter; Gwen Baillargeon; Krista Bossi; Laura Gandolfo; Carrie Light; David Bishop; Robert J Desnick
Journal:  Am J Med       Date:  2014-07-10       Impact factor: 4.965

8.  RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Senkottuvelan Kadirvel; Chunli Yu; John D Phillips; Maria I New; Abigail Liebow; Kevin Fitzgerald; William Querbes; Robert J Desnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

9.  The syndrome of inappropriate antidiuretic hormone secretion (SIADH) and neurological crisis due to acute intermittent porphyria, successfully treated with haemodialysis.

Authors:  R A Annigeri; V M Ganesan
Journal:  J Assoc Physicians India       Date:  2007-09

Review 10.  An update of clinical management of acute intermittent porphyria.

Authors:  Elena Pischik; Raili Kauppinen
Journal:  Appl Clin Genet       Date:  2015-09-01
View more
  2 in total

1.  Paediatric porphyria and human hemin: a treatment challenge in a lower middle income country.

Authors:  Syeda Anum Fatima; Humaira Jurair; Qalab Abbas; Arshalooz Jamila Rehman
Journal:  BMJ Case Rep       Date:  2020-01-08

Review 2.  Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know.

Authors:  Petro E Petrides
Journal:  Diagnostics (Basel)       Date:  2022-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.